Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Resmed (RMD)
NYSE:RMD
Resmed (RMD) Stock Price & Analysis
897 Followers
RMD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$131.19 - $230.54
Previous Close$213.82
Volume781.05K
Average Volume (3M)1.11M
Market Cap
$31.41B
Enterprise Value$32.59B
Total Cash (Recent Filing)$210.25M
Total Debt (Recent Filing)$1.39B
Price to Earnings (P/E)32.9
Beta1.10
Next Earnings
Aug 01, 2024EPS Estimate
$2.08Last Dividend Ex-Date
May 08, 2024Dividend Yield0.88%
Share Statistics
EPS (TTM)6.50
Shares Outstanding146,907,207
10 Day Avg. Volume1,100,521
30 Day Avg. Volume1,107,511
Standard Deviation0.09
R-Squared0.15
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)28.77
Price to Sales (P/S)7.44
Price to Cash Flow (P/CF)28.80
P/FCF Ratio30.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue8.14
Enterprise Value/Gross Profit13.84
Enterprise Value/Ebitda23.47
Forecast
1Y Price Target
$216.75Price Target Upside-0.52% Downside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Resmed News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceRevenue and Non-GAAP EPS beat consensus, reflecting the company's strong financial performance.
Healthcare ImpactRMD's data indicates that weight loss drug patients are more likely to start CPAP therapy and have a higher resupply rate, providing a potential boost to the company.
Market Share And DemandRMD is positioned to maintain substantial US market share gains for a longer period than anticipated, supporting an EPS leverage thesis.
Bears Say
Market CompetitionThe consent decree terms reflect FDA's view of Philips having multiple violations, including failure to address prior violations and continued violative manufacturing practices.
Product Efficacy ConcernsWeight loss drugs are not an obstructive sleep apnea cure: Only a small percentage of patients achieved a 'normal' AHI which might not significantly reduce CPAP therapy usage.
Regulatory ChallengesPhilips has agreed on the final terms of the CPAP consent decree which includes a permanent injunction on new CPAP sales.
---
Ownership Overview
2.71% Insiders
21.81% Mutual Funds
27.50% Other Institutional Investors
47.98% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMD FAQ
What was Resmed’s price range in the past 12 months?
Resmed lowest stock price was $131.19 and its highest was $230.54 in the past 12 months.
What is Resmed’s market cap?
Currently, no data Available
When is Resmed’s upcoming earnings report date?
Resmed’s upcoming earnings report date is Aug 01, 2024 which is in 79 days.
How were Resmed’s earnings last quarter?
Resmed released its earnings results on Apr 25, 2024. The company reported $2.13 earnings per share for the quarter, beating the consensus estimate of $1.927 by $0.203.
Is Resmed overvalued?
According to Wall Street analysts Resmed’s price is currently Overvalued.
Does Resmed pay dividends?
Resmed pays a Quarterly dividend of $0.48 which represents an annual dividend yield of 0.88%. See more information on Resmed dividends here
What is Resmed’s EPS estimate?
Resmed’s EPS estimate is $2.08.
How many shares outstanding does Resmed have?
Resmed has 146,907,210 shares outstanding.
What happened to Resmed’s price movement after its last earnings report?
Resmed reported an EPS of $2.13 in its last earnings report, beating expectations of $1.927. Following the earnings report the stock price went up 18.89%.
Which hedge fund is a major shareholder of Resmed?
Among the largest hedge funds holding Resmed’s share is Greenvale Capital LLP. It holds Resmed’s shares valued at 95M.
---
Resmed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$216.75 (-0.52% Downside)
$216.75 (-0.52% Downside)
Blogger Sentiment
Bullish
RMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 306.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-7.45%
12-Months-Change
Fundamentals
Return on Equity
22.39%
Trailing 12-Months
Asset Growth
1.50%
Trailing 12-Months
Company Description
Resmed
Founded in 1989, California-based ResMed, Inc. is a medical equipment company. The company is engaged in the development, manufacturing, distribution, and marketing of medical equipment and software solutions. The company operates through two segments: Sleep and Respiratory Care, and SaaS (Software as a Service).
---
RMD Company Deck
---
RMD Earnings Call
Q3 2024
0:00 / 0:00
---
RMD Revenue Breakdown
53.77% Devices
34.44% Masks and other
11.79% Software as a Service
---
RMD Stock 12 Month Forecast
Average Price Target
$216.75
▼(-0.52% Downside)
Technical Analysis
Best Analysts Covering RMD
1 Year
1 Year Success Rate
9/13 ratings generated profit
1 Year Average Return
+9.95%
reiterated a buy rating 18 days ago
Copying Lyanne Harrison's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +9.95% per trade.
---